Evidence map›Paper›PMID 24513568›Full record

ArticleViruses2014

The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody.

Aurelija Zvirbliene, Indre Kucinskaite-Kodze, Ausra Razanskiene, Rasa Petraityte-Burneikiene, Boris Klempa, Rainer G Ulrich, Alma Gedvilaite

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Aurelija ZvirblieneVilnius University Institute of Biotechnology, V.A. Graiciuno 8, Vilnius LT-02241, Lithuania. aurelija.zvirbliene@bti.vu.lt.
Indre Kucinskaite-KodzeVilnius University Institute of Biotechnology, V.A. Graiciuno 8, Vilnius LT-02241, Lithuania. indre.kodze@bti.vu.lt.
Ausra RazanskieneVilnius University Institute of Biotechnology, V.A. Graiciuno 8, Vilnius LT-02241, Lithuania. ausra.razanskiene@bti.vu.lt.
Rasa Petraityte-BurneikieneVilnius University Institute of Biotechnology, V.A. Graiciuno 8, Vilnius LT-02241, Lithuania. rasa.burneikiene@bti.vu.lt.
Boris KlempaInstitute of Medical Virology, Helmut-Ruska-Haus, Charité Medical School, Berlin 10117, Germany. boris.klempa@charite.de.
Rainer G UlrichInstitute for Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Südufer 10, Greifswald-Insel Riems 17493, Germany. Rainer.Ulrich@fli.bund.de.
Alma GedvilaiteVilnius University Institute of Biotechnology, V.A. Graiciuno 8, Vilnius LT-02241, Lithuania. alma.gedvilaite@bti.vu.lt.
Vilnius University · LTFriedrich-Loeffler-Institut · DESlovak Academy of Sciences · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monoclonal antibodies (MAbs) against viral glycoproteins have important diagnostic and therapeutic applications. In most cases, the MAbs specific to viral glycoproteins are raised against intact virus particles. The biosynthesis of viral glycoproteins in heterologous expression systems such as bacteria, yeast, insect or mammalian cells is often problematic due to their low expression level, improper folding and limited stability. To generate MAbs against hantavirus glycoprotein Gc, we have used initially a recombinant yeast-expressed full-length Puumala virus (PUUV) Gc protein. However, this approach was unsuccessful. As an alternative recombinant antigen, chimeric virus-like particles (VLPs) harboring a segment of PUUV Gc glycoprotein were generated in yeast Saccharomyces cerevisiae. A 99 amino acid (aa)-long segment of Gc protein was inserted into the major capsid protein VP1 of hamster polyomavirus at previously defined positions: either site #1 (aa 80-89) or site #4 (aa 280-289). The chimeric proteins were found to self-assemble to VLPs as evidenced by electron microscopy. Chimeric VLPs induced an efficient insert-specific antibody response in immunized mice. Monoclonal antibody (clone #10B8) of IgG isotype specific to hantavirus Gc glycoprotein was generated. It recognized recombinant full-length PUUV Gc glycoprotein both in ELISA and Western blot assay and reacted specifically with hantavirus-infected cells in immunofluorescence assay. Epitope mapping studies revealed the N-terminally located epitope highly conserved among different hantavirus strains. In conclusion, our approach to use chimeric VLPs was proven useful for the generation of virus-reactive MAb against hantavirus Gc glycoprotein. The generated broadly-reactive MAb #10B8 might be useful for various diagnostic applications.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, ViralBlotting, WesternCapsid ProteinsEnzyme-Linked Immunosorbent AssayEpitope MappingEpitopesGlycoproteinsMiceMice, Inbred BALB CPolyomavirusPuumala virusRecombinant Fusion ProteinsSaccharomyces cerevisiaeViral ProteinsAntibodies, MonoclonalAntibodies, ViralCapsid ProteinsEpitopesGlycoproteinsRecombinant Fusion ProteinsViral ProteinsVirosomes

Identifiers

PMID24513568
PMCPMC3939476
OpenAlexW2138890688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.